Benitec Biopharma (NASDAQ:BNTC – Get Free Report) will be issuing its quarterly earnings data on Monday, February 12th. Benitec Biopharma (NASDAQ:BNTC – Get Free Report) last posted its earnings results on Monday, November 13th. The biotechnology company reported ($2.76) earnings per share (EPS) for the quarter. Benitec Biopharma Price Performance Shares of BNTC opened at […]
Benitec Biopharma Inc. (NASDAQ:BNTC – Get Free Report) saw a significant decline in short interest in the month of January. As of January 15th, there was short interest totalling 6,200 shares, a decline of 18.4% from the December 31st total of 7,600 shares. Based on an average trading volume of 9,000 shares, the short-interest ratio […]
Benitec Biopharma (NASDAQ:BNTC – Free Report) had its target price boosted by JMP Securities from $6.00 to $8.00 in a report released on Wednesday, Benzinga reports. The firm currently has a market outperform rating on the biotechnology company’s stock. Benitec Biopharma Trading Up 4.4 % NASDAQ:BNTC opened at $3.07 on Wednesday. The stock has a […]
Benitec Biopharma (NASDAQ:BNTC – Get Free Report) had its price objective upped by equities research analysts at JMP Securities from $6.00 to $8.00 in a research report issued on Wednesday, Benzinga reports. The firm currently has a “market outperform” rating on the biotechnology company’s stock. JMP Securities’ price objective indicates a potential upside of 166.67% […]
Benitec Biopharma Inc. (NASDAQ:BNTC – Get Free Report) was the recipient of a large drop in short interest during the month of November. As of November 15th, there was short interest totalling 33,400 shares, a drop of 28.2% from the October 31st total of 46,500 shares. Currently, 1.5% of the company’s shares are sold short. […]